Use of potassium iodide in Dermatology: Updates on an old drug;Uso do iodeto de potássio na Dermatologia: Considerações atuais de uma droga antiga

Anais Brasileiros de Dermatologia

Volumn 88, Issue 3, 2013, Pages 396-402

  Orofino Costa, Rosane ^a   de Macedo, Priscila Marques ^a   Carvalhal, Aline ^b   Bernardes Engemann, Andréa Reis ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Iodine; Potassium iodide; Skin diseases; Therapeutics

Indexed keywords

POTASSIUM IODIDE;

ACNE; BLURRED VISION; BULLOUS PEMPHIGOID; CLINICAL TRIAL (TOPIC); COLPOSCOPY; CONJUNCTIVAL HYPEREMIA; DERMATITIS; DERMATITIS HERPETIFORMIS; DERMATOLOGY; DRUG EFFICACY; DRUG SAFETY; ENTOMOPHTHOROMYCOSIS; FEVER; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERSALIVATION; KIDNEY FAILURE; LACRIMATION DISORDER; METABOLIC ACIDOSIS; NUCLEAR ACCIDENT; PUSTULAR PSORIASIS; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT DISEASE; REVIEW; RHINORRHEA; SKIN DISEASE; SKIN INFECTION; SPOROTRICHOSIS; THYROID DISEASE;

DERMATOLOGIC AGENTS; HUMANS; POTASSIUM IODIDE; SKIN DISEASES; THYROID DISEASES; THYROID GLAND;

EID: 84879596550     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20132377     Document Type: Review

References (35)

1. Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43:691-7.
2. Horio T, Danno K, Okamoto H, Miyachi Y, Imamura S. Potassium iodide in erythe-ma nodosum and other erythematous dermatoses. J Am Acad Dermatol.1983;9:77-81
3. Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporo-trichosis with one daily dose of potassium iodide. Pediatr Infect Dis J. 1996; 15:352-4.
4. Sweetman S. Martindale: the complete drug reference. United Kingdom: Pharmaceutical Press; 2009. p. 2169-70.
5. Kirk, TG. The Merck index. 12th ed.New York: Merck & Co; 1996. p. 7809
6. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol. 1982;107:209-14.
7. Honma K, Saga K, Onodera H, Takahashi M. Potassium iodide inhibits neutrophil chemotaxis. Acta DermVenereol. 1990;70:247-9.
8. Torres-Mendonza BM, Vásquez-Valls E, González-Mendonza A. Effect of potas-sium iodide on the immune response in the sporotrichosis. Rev Iberoam Micol. 1997;14:98-100.
9. Hiruma M, Kagawa S. Ultrastructure of Sporothrixschenckii treated with iodine-potassium solution. Mycopathologia. 1987;97:121-7.
10. Vaisman M, Rosenthal D, Carvalho DP. Enzymes involved in thyroid iodide organi-fication. Arq Bras Endocrinol Metab.2004;48:7-13.
11. Albino CC, Takahashi MH, Senhonni Junior S, Graf H. Inquérito sobre o uso de iodo-131 no Brasil. Arq Bras Endocrinol Metab.2001;45:558-62.
12. Prograd.uff.br [Internet]. Farmacologia do aparelho respiratório [acesso 11 Dez 2012]. Disponível em: http://www.proac.uff.br/farmacoclinica/sites/default/files/9_APARELHO_RESPIRATORIO_Tosse_e_antigripais.pdf
13. Adalja AA. Use of potassium iodide (KI) in a nuclear emergency.BiosecurBioterror. 2011;9:405-7.
14. Conceição JCJ, Silveira CMG, Bandeira D. Neoplasias intra-epiteliais cervicais e câncer do colo do útero. In: Conceição JCJ, editor. Ginecologia Fundamental. São Paulo: Atheneu; 2005. p. 185.
15. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis 1995;21:981-5.
16. Kauffman CA. Sporotrichosis. Clin Infet Dis.1999;29:231-6.
17. Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007;25:181-7.
18. Kauffman CA, Bustamante B, Chapman SW, Pappas PG; Infectious Diseases Society of America. Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America. IDSAGuidelines for management of Sporotrichosis. Clin Infect Dis. 2007;45:1255-65.
19. Mendiratta V, Karmakar S, Jain A, Jabeen M. Severe cutaneous zygomycosis dueto Basidiobolusranarum in a young infant. Pediatr Dermatol.2012;29:121-3.
20. Narendranath S, Sudhakar GK, Pai MR, Kini H, Pinto J, Pai MR. Safety and effica-cy of oral potassium iodide in chromoblastomycosis. Int J Dermatol. 2010;49:341-3.
21. Khan FA, Hashmi S, Sarwari AR. Multiple subcutaneous mycetomas caused by Pseudallescheriaboydii: response to therapy with oral potassium iodide solution. J Infect. 2010;60:178-81.
22. Aozasan N, Kiso M, Kaneko T. Primary lymphocutaneousnocardiosis due to Nocardiabrasiliensis which was successfully treated with only oral potassium iodi-de. J Dermatol. 2011;38:826-8.
23. Asahina A, Minatami Y, Tada Y, Mitsui H, Tamaki K. Successful treatment of pyo-dermagangrenosum with potassium iodide. Acta DermVenereol. 2006;84-5.
24. Koguchi H, Arita K, Yamane N, Shinkuma S, Shimizu H. Erythema annularecentri-fugum-like neutrophilicdermatoses: effects of potassium iodide. Acta DermVenereol. 2012;92:333-4.
25. Smith JB, Hansen CD, Zone JJ. Potassium iodide in the treatment of disseminated granuloma annulare. J Am Acad Dermatol.1994;30:791-2.
26. Campbell I, Pacheco TMV. Esporotricose. In: Zaitz C, Marques SA, Ruiz LRB, Framil VMS editores. Compêndio de micologia médica. Rio de Janeiro: Guanabara Koogan; 2010. p. 349.
27. Sampaio S, Rivitti E. Terapêutica sistêmica. In: Sampaio S, Rivitti E, editores. Dermatologia. São Paulo: Artes médicas; 2007. p. 1437-1438.
28. Nunley JR, Wolverton S, Darst M. Systemicdrugs. In: Bolognia JL, Jorizzo JL, Rapini RP editors. Dermatology.2nd ed. Madri: Mosby Elsevier; 2008. p. 2017-8.
29. Bennett JE. Agentesantifúngicos. In: Gilman AG, Goodman AG. Goodman & Gilman: as bases farmacológicas da terapêutica. 10.ed. Rio de Janeiro: Guanabara-Koogan, 2001. p.977-8.
30. Who.int [Internet]. WHO Model Prescribing Information: Drugs used in skin disea-ses [cited 2012 Dez12]. Disponível em: http://apps.who.int/medicinedocs/en/d/Jh2918e/24.12.html#Jh2918e.24.12
31. Donadel KW, Reinoso YD, Oliveira JC, Azulay RD. Esporotricose. An Bras Dermatol.1993;68:42-52.
32. Peet M, Yates RA, Shields AG. Dose-response relationship for mydriasis produced by topical ocular tyramine in man. Br J Clin Pharmacol. 1980;9:96-8.
33. Heymann WR. Potassium iodide and the Wolff-Chaikoff effect: relevance for the dermatologist. J Am Acad Dermatol. 2000;42:490-2.
34. Hollander L, Fetterman GH. Fatal iododerma: the eleventh case reported in the lite-rature. Arch Dermatol Syphilol. 1936;34:228-41.
35. Miller DW. Extrathyroidal benefits of iodine. J Am Phys Surg. 2006;11:106-10.